
Blue Jet Health Sees Revision in Market Evaluation Amid Mixed Financial Signals
2025-11-27 10:06:18Blue Jet Health, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a complex interplay of financial and technical factors. The recent assessment highlights challenges in operational cash flow and technical indicators, despite strong quality metrics, prompting a reassessment of the company’s market standing.
Read More
Blue Jet Healthcare Soars 7.97%, Hits Intraday High of Rs 597.9
2025-11-07 15:04:01Blue Jet Healthcare has seen a notable increase today, recovering from previous declines and outperforming its sector. Despite this uptick, the stock remains below key moving averages and has experienced significant volatility. Over the past three months, it has declined, though it has shown positive growth over the past year.
Read More
Blue Jet Healthcare Hits Day Low at Rs 557.3 Amid Price Pressure
2025-11-06 11:48:50Blue Jet Healthcare's stock has declined significantly, marking its second consecutive day of losses. The stock is underperforming relative to its sector and is trading below key moving averages. The broader market, including the Medical Equipment sector, is also experiencing a downturn amid challenging conditions.
Read More
Blue Jet Healthcare Faces Mixed Financial Performance Amidst Growth and Challenges
2025-11-06 08:00:30Blue Jet Healthcare's recent financial results reveal a mixed performance for the quarter ending September 2025. While net sales and profit after tax showed significant growth over six months, the quarterly PAT and operating cash flow declined sharply. The company also reported its highest dividend per share, despite facing operational challenges.
Read MoreHow has been the historical performance of Blue Jet Health?
2025-11-04 22:59:07Answer: The historical performance of Blue Jet Health shows a decline in net sales and profit from March 2020 to March 2021. Breakdown: In the fiscal year ending March 2021, Blue Jet Health reported net sales of 498.93 Cr, down from 538.20 Cr in the previous year. Total operating income also decreased to 498.93 Cr from 538.20 Cr. The raw material cost rose to 214.27 Cr from 186.60 Cr, while the total expenditure, excluding depreciation, fell to 292.88 Cr from 324.47 Cr. Operating profit (PBDIT) decreased slightly to 214.93 Cr from 219.54 Cr, and profit before tax declined to 184.66 Cr from 194.13 Cr. Consequently, profit after tax also dropped to 135.79 Cr from 144.96 Cr. The earnings per share (EPS) saw a significant reduction, falling to 27.4 from 483.2. On the balance sheet, total liabilities increased to 536.27 Cr from 373.85 Cr, while total assets rose to 536.27 Cr from 373.85 Cr. The company experien...
Read MoreAre Blue Jet Health latest results good or bad?
2025-11-04 19:49:53Blue Jet Healthcare's latest financial results for Q2 FY26 reflect significant operational challenges, particularly in revenue generation. The company reported net sales of ₹165.48 crores, which marks a substantial sequential decline of 53.35% from ₹354.76 crores in Q1 FY26, and a year-on-year decrease of 20.54% from ₹208.26 crores in Q2 FY25. This decline is notable as it represents the lowest quarterly revenue figure in recent tracking periods, raising concerns about the sustainability of the company's growth trajectory. Net profit for the quarter was ₹52.14 crores, down 42.82% quarter-on-quarter and 10.64% year-on-year. While the profit after tax margin improved to 31.51% from the previous quarter, the absolute profit figures have caused apprehension among investors, as this decline in profitability coincides with the revenue drop. Operating margins stood at 33.21%, reflecting a modest decline of 89 ba...
Read More
Blue Jet Healthcare Q2 FY26: Sharp Revenue Decline Triggers 10% Stock Plunge Despite Healthy Margins
2025-11-04 15:32:48Blue Jet Healthcare Limited reported a net profit of ₹52.14 crores for Q2 FY26, marking a steep decline of 42.82% quarter-on-quarter and 10.64% year-on-year, as revenue contracted sharply amid operational challenges. The stock tumbled 10.00% to ₹607.30 following the results announcement, reflecting investor disappointment with the company's performance despite maintaining relatively healthy operating margins of 33.21%.
Read More
Blue Jet Healthcare Stock Hits Lower Circuit Limit at Rs 606.65 Amid Significant Decline
2025-11-04 14:00:14Blue Jet Healthcare Ltd faced notable volatility, closing at Rs 606.65 after a significant decline. The stock reached an intraday high of Rs 688.5 before dropping, with a wide trading range and increased investor participation. However, it remains below key moving averages, indicating a bearish trend.
Read More
Blue Jet Healthcare Faces 10% Decline Amid Significant Selling Pressure and Consecutive Losses
2025-11-04 13:51:23Blue Jet Healthcare Ltd is experiencing significant selling pressure, with a notable decline in its stock price. The company has faced consecutive losses over recent days and a marked downturn over the past month and three months. Its performance contrasts sharply with the Sensex, highlighting a challenging market position.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
08-Nov-2025 | Source : BSEAs attached
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2025 | Source : BSENewspaper publication of financial result for quarter and half year ended September 2025
Announcement under Regulation 30 (LODR)-Investor Presentation
04-Nov-2025 | Source : BSEInvestor Presentation on Financial Results for the quarter and half year ended September 30 2025
Corporate Actions
No Upcoming Board Meetings
Blue Jet Healthcare Ltd has declared 60% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available






